Overview

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
0
Participant gender:
Female
Summary
This trial aims to assess efficacy and safety of an intraperitoneal, aerosol, high-pressure chemotherapy in women with recurrent ovarian cancer
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ruhr University of Bochum
Treatments:
Cisplatin
Doxorubicin
Liposomal doxorubicin
Criteria
Inclusion Criteria:

- at least 2 lines of previous chemotherapy

- recurrent ovarian cancer

- patient is mobile

- informed consent

Exclusion Criteria:

- ileus

- necessity of parenteral nutrition